Personalized treatment is ideal for multiple sclerosis (MS) owing to the heterogeneity of
clinical features, but current knowledge gaps, including validation of biomarkers and …

In recent years, several studies have examined the potential associations between
mitochondrial dysfunction and neurodegenerative diseases such as multiple sclerosis (MS) …

Multiple sclerosis (MS) is a chronic debilitating inflammatory disease of unknown ethology
targeting the central nervous system (CNS). MS has a polysymptomatic onset and is usually …

While the etiology of multiple sclerosis (MS) remains unclear, research from the clinic and
preclinical models identified the essential role of inflammation and demyelination in the …

Background Multiple sclerosis (MS) is a chronic autoimmune disease of CNS with a highly
heterogeneous clinical course. The role of the genetic variability in determination of MS …

Background and purpose Treatment options in primary progressive multiple sclerosis
(PPMS) are scarce and, with the exception of ocrelizumab, anti‐inflammatory agents have …

Clinical trials of new treatments in multiple sclerosis (MS) currently require large sample
sizes and long durations in order to yield reliable results. The differential responses of an …

We studied the effects of metabolic cold adaptation (MCA) in two populations of a
eurythermal species, spotted seatrout (Cynoscion nebulosus) along the US East Coast. Fish …

Amaç Primer progresif multipl skleroz (PPMS) ve progresif relapsing multipl skleroz (PRMS)
başlangıçtan beri olan progresyon ile karakterize MS tipleridir. Nadir görülmelerinden …

Multiple sclerosis is a chronic disease of the central nervous system, combining in its
pathogenesis both autoimmune and neurodegenerative components, and is characterized …